BusinessINC Research Appoints William E. Klitgaard and Linda S. Harty to Board of DirectorsBy Nasdaq OMXMar 3, 2017, 1:12 PM UTC
BusinessBlake Insomnia Therapeutics and Sajo Consulting Introduce Clinical Trial Team MembersBy Nasdaq OMXMar 2, 2017, 2:49 PM UTC
BusinessBlake Insomnia Therapeutics Inc. Closes Joint Venture with Sajo Consulting LLCBy Nasdaq OMXFeb 25, 2017, 1:08 AM UTC
BusinessBiothera Pharmaceuticals Initiates Patient Dosing in Phase 2 Trial Investigating Imprime PGG and Merck’s KEYTRUDA® (pembrolizumab)By Nasdaq OMXFeb 23, 2017, 2:01 PM UTC
BusinessBiothera Pharmaceuticals Initiates Patient Dosing in Phase 2 Trial Investigating Imprime PGG and Merck’s KEYTRUDA® (pembrolizumab)By Nasdaq OMXFeb 23, 2017, 2:01 PM UTC
BusinessAssembly Biosciences Announces Successful Completion of ABI-H0731 Phase 1a Trial and Upcoming Conference PresentationsBy Nasdaq OMXFeb 16, 2017, 12:05 PM UTC
BusinessITL Pharma Receives United States Patent Protection for TriThroid® Using Sustained Drug Release and Improved Product StabilityBy Nasdaq OMXFeb 14, 2017, 2:10 PM UTC
BusinessINC Research Further Strengthens Board of Directors Through Appointment of Pharmaceutical Executive Eric P. PâquesBy Nasdaq OMXFeb 8, 2017, 10:12 PM UTC
